Search Results

Apolipoprotein E in dense deposits: a parting of the ways in C3 glomerulopathy.

• Authors : Tavares, Joana¹ (AUTHOR); Caravaca-Fontán, Fernando² (AUTHOR) ; Praga, Manuel³ (AUTHOR)

Subjects: *APOLIPOPROTEIN E; *ECULIZUMAB; *MACULAR degeneration

• Source: Clinical Kidney Journal. Jun2024, Vol. 17 Issue 6, p1-2. 2p.

Record details

Podocyte puzzle: IgA nephropathy.

• Authors : Bharati, Joyita^1,2 (AUTHOR); Munir, Kiran¹ (AUTHOR); Jhaveri, Kenar D¹ (AUTHOR)

Subjects: *IGA glomerulonephritis; *ECULIZUMAB; *IMMUNE complexes

• Source: Clinical Kidney Journal. Dec2023, Vol. 16 Issue 12, p2760-2761. 2p.

Record details

Prognosis is still poor in patients with posttransplant C3 glomerulopathy despite eculizumab use.

• Authors : Mirioglu S; Division of Nephrology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey.; Department of Immunology, Istanbul University Aziz Sancar Institute of Experimental Medicine, Istanbul, Turkey.

• Source: Clinical kidney journal [Clin Kidney J] 2024 Jun 20; Vol. 17 (7), pp. sfae190. Date of Electronic Publication: 2024 Jun 20 (Print Publication: Publisher: Oxford University Press Country of Publication: England NLM ID: 101579321 Publication Model: eCollection Cited Medium: Print ISSN:

Record details

Eculizumab discontinuation in atypical haemolytic uraemic syndrome: TMA recurrence risk and renal outcomes.

• Authors : Ariceta, Gema; Fakhouri, Fadi; Sartz, Lisa

Subjects: HEMOLYTIC-uremic syndrome; ECULIZUMAB; KIDNEY failure

• Source: Clinical Kidney Journal; Sep2021, Vol. 14 Issue 9, p2075-2084, 10p

Record details

Outcome of atypical haemolytic uraemic syndrome relapse after eculizumab withdrawal.

• Authors : Duineveld, Caroline; Bouwmeester, Romy; Heijden, Joost W van der

Subjects: HEMOLYTIC-uremic syndrome; ECULIZUMAB; TRANSPLANTATION of organs, tissues, etc.NETHERLANDS

• Source: Clinical Kidney Journal; Aug2021, Vol. 14 Issue 8, p1939-1945, 7p

Record details

Dobrava hantavirus and coinciding SARS-CoV-2 infection mimicking thrombotic microangiopathy and responding to a single dose of eculizumab.

• Authors : Aberger S; Department of Internal Medicine I, Paracelsus Medical University, Salzburg, Austria.; Kozakowski N

• Source: Clinical kidney journal [Clin Kidney J] 2023 Sep 27; Vol. 16 (12), pp. 2750-2753. Date of Electronic Publication: 2023 Sep 27 (Print Publication: Publisher: Oxford University Press Country of Publication: England NLM ID: 101579321 Publication Model: eCollection Cited Medium: Print ISSN:

Record details

Atypical hemolytic uremic syndrome in Brazil: clinical presentation, genetic findings and outcomes of a case series in adults and children treated with eculizumab.

• Authors : Palma, Lilian Monteiro Pereira; Eick, Renato George; Dantas, Gustavo Coelho

Subjects: HEMOLYTIC-uremic syndrome; THROMBOTIC thrombocytopenic purpura; ECULIZUMABBRAZIL

• Source: Clinical Kidney Journal; Apr2021, Vol. 14 Issue 4, p1126-1135, 10p

Record details

Should eculizumab be discontinued in patients with atypical hemolytic uremic syndrome?

• Authors : Rodriguez, Eva^1,2; Barrios, Clara^1,2; Soler, Maria José^1,2

Subjects: *ECULIZUMAB; *KIDNEY disease treatments; *KIDNEY disease diagnosis

• Source: Clinical Kidney Journal. Jun2017, Vol. 10 Issue 3, p320-322. 3p.

Record details

Use of eculizumab in crescentic IgA nephropathy: proof of principle and conundrum?

• Authors : Ring, Troels¹ ; Bang Pedersen, Birgitte¹; Salkus, Giedrius²

Subjects: *IGA glomerulonephritis; *ECULIZUMAB; *PROTEINURIA

• Source: Clinical Kidney Journal. Oct2015, Vol. 8 Issue 5, p489-491. 3p.

Record details

Eculizumab for rescue of thrombotic microangiopathy in PM-Scl antibody-positive autoimmune overlap syndrome.

• Authors : Nester, Carla M.^1,2; Thomas, Christie P.^1,2,3; Sharma, Manisha⁴

Subjects: *ECULIZUMAB; *THROMBOTIC thrombocytopenic purpura treatment; *SYSTEMIC scleroderma

• Source: Clinical Kidney Journal. Dec2015, Vol. 8 Issue 6, p698-701. 4p.

Record details